| Product Name | Lapatinib - API |
| Product Code | DA-L017-i |
| Chemical name | Lapatinib |
| Synonyms | N-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-amine; |
| Impurity | NA |
| CAS Number | 231277-92-2 |
| Alternate CAS # | NA |
| Molecular form | C29H26ClFN4O4S |
| Appearance | Pale Yellow Solid |
| Melting Point | NA |
| Mol. Weight | 581.06 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | Fine Chemicals,pharmaceutical standards,metabolites,impurities,intermediates |
| Boiling Point | NA |
| Applications | Lapatinib is a selective inhibitor of epidermal growth factor receptor (EGFR) and HER-2 tyrosine kinases. This drug is used to treat breast cancer, especially metastatic breast cancer that has progressed after trastuzumab treatment and other chemotherapy. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
